Rapid Evolution of Multidrug Resistance in a Candida lusitaniae Infection during Micafungin Monotherapy.

Humans Micafungin / therapeutic use Antifungal Agents / pharmacology Fluconazole / therapeutic use Candidiasis / drug therapy Candida Echinocandins / pharmacology Drug Resistance, Fungal / genetics Drug Resistance, Multiple Microbial Sensitivity Tests
Candida lusitaniae ERG3 FKS1 antifungal drug resistance echinocandin

Journal

Antimicrobial agents and chemotherapy
ISSN: 1098-6596
Titre abrégé: Antimicrob Agents Chemother
Pays: United States
ID NLM: 0315061

Informations de publication

Date de publication:
17 08 2023
Historique:
medline: 18 8 2023
pubmed: 10 7 2023
entrez: 10 7 2023
Statut: ppublish

Résumé

Candida (Clavispora) lusitaniae is a rare, emerging non-

Identifiants

DOI: 10.1128/aac.00543-23 PMID: 37428075 PMC: PMC10433866
pubmed: 37428075
doi: 10.1128/aac.00543-23
pmc: PMC10433866
doi:

Substances chimiques

Micafungin R10H71BSWG
Antifungal Agents 0
Fluconazole 8VZV102JFY
Echinocandins 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e0054323

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI143689
Pays : United States

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Références

Bioinformatics. 2017 Oct 01;33(19):3088-3090
pubmed: 28575171
Bioinformatics. 2014 Aug 1;30(15):2114-20
pubmed: 24695404
Diagn Microbiol Infect Dis. 1994 Nov;20(3):127-33
pubmed: 7874879
Drug Resist Updat. 2015 Nov;23:12-19
pubmed: 26690338
PLoS Comput Biol. 2021 Jan 27;17(1):e1008678
pubmed: 33503026
Front Microbiol. 2020 Aug 27;11:1994
pubmed: 32983018
Brief Bioinform. 2013 Mar;14(2):178-92
pubmed: 22517427
Genome Announc. 2017 Aug 3;5(31):
pubmed: 28774979
Biochem Biophys Res Commun. 1989 Nov 15;164(3):1170-5
pubmed: 2556119
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Nat Commun. 2019 Jul 25;10(1):3313
pubmed: 31346170
Clin Infect Dis. 2001 Jan 15;32(2):186-90
pubmed: 11170906
Nature. 2013 Aug 29;500(7464):571-4
pubmed: 23873039
Open Forum Infect Dis. 2019 Mar 15;6(Suppl 1):S79-S94
pubmed: 30895218
Antimicrob Agents Chemother. 2017 Aug 24;61(9):
pubmed: 28630186
Nucleic Acids Res. 2016 Jul 8;44(W1):W160-5
pubmed: 27079975
Antimicrob Agents Chemother. 2022 May 17;66(5):e0172521
pubmed: 35412354
Antimicrob Agents Chemother. 2015 Dec;59(12):7715-22
pubmed: 26438490
Gene. 1987;57(2-3):267-72
pubmed: 3319781
BMC Bioinformatics. 2016 Apr 19;17:172
pubmed: 27094401
Nat Rev Microbiol. 2020 Jun;18(6):319-331
pubmed: 32047294
Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0051721
pubmed: 34228535
Mol Biol Evol. 2023 Jan 4;40(1):
pubmed: 36649220
Antimicrob Agents Chemother. 1995 Dec;39(12):2708-17
pubmed: 8593007
mBio. 2019 Dec 24;10(6):
pubmed: 31874914
Nat Commun. 2018 Jun 25;9(1):2470
pubmed: 29941885
mBio. 2023 Apr 25;14(2):e0022723
pubmed: 36877011
Antimicrob Agents Chemother. 2020 Aug 20;64(9):
pubmed: 32571812
Antimicrob Agents Chemother. 2003 Sep;47(9):2717-24
pubmed: 12936965
J Infect Dis. 2017 Aug 15;216(suppl_3):S445-S451
pubmed: 28911043
Genetica. 1998;102-103(1-6):127-44
pubmed: 9720276
Bioinform Biol Insights. 2016 Jun 07;10:59-72
pubmed: 27279736
Gigascience. 2021 Feb 16;10(2):
pubmed: 33590861
Elife. 2020 Jul 20;9:
pubmed: 32687060
Bioinformatics. 2018 Mar 1;34(5):867-868
pubmed: 29096012
Antimicrob Agents Chemother. 2013 Jul;57(7):3182-93
pubmed: 23629718
Nat Chem Biol. 2014 May;10(5):400-6
pubmed: 24681535
Antimicrob Agents Chemother. 2010 Nov;54(11):4527-33
pubmed: 20733039
J Clin Microbiol. 1992 Nov;30(11):3005-8
pubmed: 1360476
Antimicrob Agents Chemother. 2005 Aug;49(8):3264-73
pubmed: 16048935
Clin Infect Dis. 2016 Feb 15;62(4):e1-50
pubmed: 26679628
Nucleic Acids Res. 2014 Jan;42(Database issue):D699-704
pubmed: 24297253
Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):12040-12045
pubmed: 30389707
Bioinformatics. 2011 Aug 1;27(15):2156-8
pubmed: 21653522
Open Forum Infect Dis. 2015 Dec 14;2(4):ofv163
pubmed: 26677456
Antimicrob Agents Chemother. 1997 Nov;41(11):2471-9
pubmed: 9371352
Nat Commun. 2018 Dec 17;9(1):5346
pubmed: 30559369
Fly (Austin). 2012 Apr-Jun;6(2):80-92
pubmed: 22728672
Antimicrob Agents Chemother. 2003 Aug;47(8):2404-12
pubmed: 12878497
J Clin Microbiol. 1989 Feb;27(2):236-40
pubmed: 2644291
Nature. 2009 Jun 4;459(7247):657-62
pubmed: 19465905
Curr Biol. 2021 Dec 6;31(23):5314-5326.e10
pubmed: 34699784
Curr Protoc Bioinformatics. 2013;43:11.10.1-11.10.33
pubmed: 25431634
Infect Control Hosp Epidemiol. 1998 May;19(5):343-5
pubmed: 9613696
Bioinformatics. 2009 Aug 15;25(16):2078-9
pubmed: 19505943
J Clin Microbiol. 1984 Dec;20(6):1194-5
pubmed: 6520227

Auteurs

Nancy E Scott (NE)

University of Minnesota, Bioinformatics and Computational Biology Program, Minneapolis, Minnesota, USA.
University of Minnesota, Department of Microbiology and Immunology, Minneapolis, Minnesota, USA.
ORCID: 0000-0003-1678-0796

Serin Edwin Erayil (S)

University of Minnesota Medical School, Department of Medicine, Division of Infectious Diseases and International Medicine, Minneapolis, Minnesota, USA.

Susan E Kline (SE)

University of Minnesota Medical School, Department of Medicine, Division of Infectious Diseases and International Medicine, Minneapolis, Minnesota, USA.

Anna Selmecki (A)

University of Minnesota, Bioinformatics and Computational Biology Program, Minneapolis, Minnesota, USA.
University of Minnesota, Department of Microbiology and Immunology, Minneapolis, Minnesota, USA.
ORCID: 0000-0003-3298-2400

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Rapid Evolution of Multidrug Resistance in a...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Peptides cycliques › Échinocandines › Micafungine › Rapid Evolution of Multidrug Resistance in a...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antifongiques › Rapid Evolution of Multidrug Resistance in a...
questionsmedicales.fr › Composés hétérocycliques › Composés hétéromonocycliques › Azoles › Triazoles › Fluconazole › Rapid Evolution of Multidrug Resistance in a...
questionsmedicales.fr › Infection › Infections bactériennes et mycoses › Mycoses › Candidose › Rapid Evolution of Multidrug Resistance in a...
questionsmedicales.fr › Eucaryotes › Champignons › Levures › Candida › Rapid Evolution of Multidrug Resistance in a...
questionsmedicales.fr › Acides aminés, peptides et protéines › Peptides › Peptides cycliques › Échinocandines › Rapid Evolution of Multidrug Resistance in a...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Résistance microbienne aux médicaments › Résistance des champignons aux médicaments › Rapid Evolution of Multidrug Resistance in a...
questionsmedicales.fr › Phénomènes physiologiques › Phénomènes pharmacologiques et toxicologiques › Phénomènes pharmacologiques › Résistance aux substances › Multirésistance aux médicaments › Rapid Evolution of Multidrug Resistance in a...
questionsmedicales.fr › Techniques d'investigation › Évaluation préclinique de médicament › Tests de sensibilité microbienne › Rapid Evolution of Multidrug Resistance in a...